Houlihan Lokey, Inc. (NYSE:HLI – Get Free Report) CEO Scott L. Beiser sold 9,084 shares of the company’s stock in a transaction on Friday, November 3rd. The shares were sold at an average price of $105.78, for a total value of $960,905.52. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Houlihan Lokey Price Performance
Shares of NYSE:HLI opened at $102.86 on Wednesday. The firm has a market capitalization of $7.13 billion, a PE ratio of 26.44 and a beta of 0.77. The business has a 50-day moving average of $105.26 and a two-hundred day moving average of $98.98. Houlihan Lokey, Inc. has a 12 month low of $83.92 and a 12 month high of $110.94.
Houlihan Lokey Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, December 15th. Shareholders of record on Friday, December 1st will be paid a dividend of $0.55 per share. The ex-dividend date is Thursday, November 30th. This represents a $2.20 annualized dividend and a yield of 2.14%. Houlihan Lokey’s dividend payout ratio is presently 56.56%.
Institutional Investors Weigh In On Houlihan Lokey
Analyst Ratings Changes
Several research firms recently commented on HLI. StockNews.com began coverage on Houlihan Lokey in a research note on Thursday, October 5th. They issued a “hold” rating for the company. Morgan Stanley upped their target price on Houlihan Lokey from $81.00 to $101.00 in a research note on Wednesday, July 12th. Finally, UBS Group upped their target price on Houlihan Lokey from $118.00 to $124.00 and gave the company a “buy” rating in a research note on Tuesday, October 3rd.
Houlihan Lokey Company Profile
Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.
- Five stocks we like better than Houlihan Lokey
- How to Invest in the Healthcare Sector
- GSK is a remedy for the winter investment blahs
- Growth Stocks: What They Are, Examples and How to Invest
- After blowout earnings, Integer may be headed to new highs
- How to Effectively Use the MarketBeat Ratings Screener
- Banking and trucking: Is the economy rolling toward troubles?
Receive News & Ratings for Houlihan Lokey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Houlihan Lokey and related companies with MarketBeat.com's FREE daily email newsletter.